"The Champagne should probably be kept on ice, at least until the two presidents put pen to paper," said state-owned media China Daily.Traderead more
U.S. stock index futures turned lower after China said it needed to have further discussions before it would sign off on the so-called phase one trade deal President Trump...US Marketsread more
Analysts say the partial U.S.-China trade deal doesn't touch on thorny issues plaguing both sides, and warn talks could break down again.World Economyread more
Economists polled by Reuters had expected Chinese exports denominated in the U.S. dollar to fall by 3% and imports to decline by 5.2% in September, compared to a year ago.China Economyread more
Economists Abhijit Banerjee, Esther Duflo and Michael Kremer won the 2019 Nobel Economics Prize for their work in fighting global poverty, the Royal Swedish Academy of...World Newsread more
Boeing's board removed CEO Dennis Muilenburg as chairman amid the fall out of two 737 Max crashes that killed 346 people.Aerospace & Defenseread more
The U.K. and EU are gearing up for what could be the busiest week in British politics since June 2016.Europe Politicsread more
The U.S. had plans to hike duties on at least $250 billion in Chinese goods to 30% from 25% on Tuesday. Despite the partial trade deal, some banks on Sunday wrote that tariff...Marketsread more
"It seems like what the two leaders have done is try to set some of the thorny political issues to the side," said Dhruva Jaishankar, director of the U.S. Initiative at the...Asia Politicsread more
Beijing will be opening up its financial industry to foreign ownership from January, namely in the areas of futures, mutual funds and securities.China Economyread more
The industry has pulled in $322 billion over the past six months, the fastest pace since the second half of 2008.Marketsread more
The New York Attorney General is suing OxyContin maker Purdue Pharma, Johnson & Johnson, McKesson Corp. and other opioid makers and drug distributors in a massive new legal fight against the industry.
The lawsuit accuses six opioid manufacturers; the Sackler family, which owns Purdue Pharma, and four prescription drug distributors of using false and deceptive marketing practices and unlawfully diverting drugs. It blames them for largely "creating the opioid epidemic that has ravaged New York, causing widespread addiction, overdose deaths, and suffering," according to a statement from the AG's office.
"We found that pharmaceutical manufacturers and distributors engaged in years of deceptive marketing about the risks of opioids and failed to exercise their basic duty to report suspicious behavior, leading to the crisis we are living with today," New York Attorney General Letitia James said in a statement.
The lawsuit accuses manufacturers of overstating the benefits of taking opioids, encouraging long-term opioid therapy, discouraging alternative treatments and downplaying risks from the highly marketed medications.
In some instances, doctors prescribed more opioids to people who showed signs of addiction. A Purdue senior medical director said patients "were not addicted, but rather simply suffering from undertreatment of their pain," according to the lawsuit.
The news comes after Purdue Pharma and the Sackler family agreed to pay $270 million to the state of Oklahoma after it alleged the drugmaker ruthlessly marketed and misled the public about OxyContin.
Purdue Pharma said in a statement that New York state "is seeking to publicly vilify Purdue and its former directors while unfairly undermining the important work we have taken to address the opioid crisis."
The Sackler family denied the allegations, saying they are "inconsistent with the factual record," according to a statement.
"Government data makes clear that the opioid crisis is growing rapidly because of illicit fentanyl smuggled in from China and Mexico — and headline-seeking lawsuits like this only distract from the important task of identifying real solutions to that crisis," the family said.
Overdose deaths from prescription opioids are five times higher now than in 1999, according to the Centers for Disease Control and Prevention. Each day, nine people in New York die from opioid-related overdoses, according to the lawsuit. OxyContin became available in 1996.
The New York lawsuit also details the alleged role pharmaceutical distributors played in the national crisis along with the manufacturers.
"Defendants caused this disaster together," the lawsuit states.